Violin MD on MSN
17 silent signs of kidney disease doctors recognize immediately - most people never see them coming
Chronic kidney disease often develops without obvious symptoms, but your body may show important warning signs long before ...
US FDA grants traditional approval for Novartis’ Fabhalta to slow kidney function decline in primary IgAN: Basel Saturday, July 18, 2026, 14:00 Hrs [IST] Novartis announced that ...
With two approved medicines to treat primary immunoglobulin A nephropathy (IgAN) and a third therapy in phase 3 testing, ...
Morning Overview on MSN
The FDA cleared the first drug shown to slow a kidney disease that silently scars the organ
Adults and children living with a rare kidney-scarring condition called focal segmental glomerulosclerosis now have the first ...
Chronic kidney disease (CKD) is a long-term condition in which the kidneys lose their ability to filter waste and extra fluid from the blood. While diabetes is ...
Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically ...
An international study found that finerenone slows kidney function decline and reduces the risk of serious kidney and ...
In a post hoc analysis of the phase 2 NOBILITY trial, researchers found that treatment with obinutuzumab - an antibody that targets a protein expressed on certain immune cells - was superior to ...
Both FSGS histology and nonresponse to rituximab conferred inferior kidney survival. Kidney survival in children with steroid-resistant nephrotic syndrome (SRNS), particularly those with focal ...
PHILADELPHIA -- Treatment with sparsentan (Filspari) led to no significant differences in estimated glomerular filtration rate (eGFR) slope compared with irbesartan among patients with focal segmental ...
Polycystic Kidney Disease often progresses silently for years. Doctors explain early symptoms, genetic risks, diagnosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results